CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 68,000 shares at $14.56 ($990,080)
- CERT Other Certification
- 8-A12B Other Registration of Securities
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 1,600 shares (grant or award)
- 4 Grant or award Director acquired 1,600 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 6,047 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 9,771 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 13,856 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 13,987 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 40,712 shares (to pay taxes)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 31,050 shares at $16.15 ($501,426)
Page 2 of 7 · 134 filings